The chemokine CXCR2 antagonist (AZD5069) preserves neutrophil-mediated host immunity in non-human primates

• Mohib Uddin,
• Catherine Betts,
• Ian Robinson,
• Anna Malmgren,
• Charles Humfrey

Affiliations

Mohib Uddin

The IMED Respiratory, Inflammation & Autoimmunity Unit, AstraZeneca Gothenburg, Mölndal, Sweden

Catherine Betts

Drug Safety and Metabolism, AstraZeneca R&D, Cambridge, U.K.

Ian Robinson

Drug Safety and Metabolism, AstraZeneca R&D, Cambridge, U.K.

Anna Malmgren

The IMED Respiratory, Inflammation & Autoimmunity Unit, AstraZeneca Gothenburg, Mölndal, Sweden

Charles Humfrey

Drug Safety and Metabolism, AstraZeneca R&D, Cambridge, U.K.